MiNK Therapeutics

INKT

10.4302.61% ( -0.280 )

Closed: Oct 26, 16:00:00 (EDT)

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: MiNK Therapeutics(INKT) the EBIT is -3.217 M (+20.62%), Miss estimate;the EPS is -0.62 (+41.51%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITMiss expectations

-0.00B20.62%

-0.00B25.97%

-0.00B5.35%

EPSMiss expectations

-0.6241.51%

-0.643.40%

-0.02001.89%

Upcoming earnings report - Q3 FY2026

Available dateNov 13, 2026

Estimate Revenue$875 K

Estimate EBIT-$2.589 M

Estimate EPS-$0.5

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly